CIK 0001810560 · Non-accelerated filer<br>Smaller reporting company
REVELATION BIOSCIENCES, INC.
Sign in to watch- Ticker
- REVB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843898466
- Phone
- 650-800-3717
- Business address
- 4660 LAJOLLA VILLAGE DRIVE, SUITE 100, SAN DIEGO, CA, 92122
- Former names
- Petra Acquisition Inc.
Securities
- REVB Common Stock Nasdaq
- REVBW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-29 | Rolke James Chief Executive Officer | Grant or award | +390,614 | $1.28 | $500K | 400,660 |
| 2025-10-29 | CARVER JENNIFER Director | Grant or award | +15,625 | $1.28 | $20K | 15,688 |
| 2025-10-29 | Zygmont Chester Stanley III Chief Financial Officer | Grant or award | +390,614 | $1.28 | $500K | 395,645 |
| 2025-10-29 | ROPER JESS Director | Grant or award | +15,625 | $1.28 | $20K | 15,686 |
| 2025-02-11 | Chawla Lakhmir S Director | Grant or award | +181 | $3.87 | $700 | 181 |
| 2025-02-11 | CARVER JENNIFER Director | Grant or award | +181 | $3.87 | $700 | 187 |
| 2025-02-11 | ROPER JESS Director | Grant or award | +181 | $3.87 | $700 | 183 |
| 2025-02-11 | Rolke James Chief Executive Officer | Grant or award | +30,095 | $3.87 | $116K | 30,137 |
| 2025-02-11 | Zygmont Chester Stanley III Chief Financial Officer | Grant or award | +15,048 | $3.87 | $58K | 15,076 |
| 2025-02-11 | TIDMARSH GEORGE F Director | Grant or award | +181 | $3.87 | $700 | 268 |
| 2023-12-08 | TIDMARSH GEORGE F Director | Sale | −27,771 | $0.52 | $14K | 0 |
| 2023-10-16 | TIDMARSH GEORGE F Director | Sale | −1,845 | $0.65 | $1K | 27,771 |
| 2023-10-16 | TIDMARSH GEORGE F Director | Sale | −10,957 | $0.66 | $7K | 42,096 |
| 2023-09-28 | TIDMARSH GEORGE F Director | Sale | −1,429 | $0.69 | $986 | 42,096 |
| 2023-09-18 | TIDMARSH GEORGE F Director | Sale | −4,000 | $0.74 | $3K | 39,348 |
| 2023-09-15 | TIDMARSH GEORGE F Director | Sale | −9,500 | $0.73 | $7K | 43,348 |
| 2023-09-14 | TIDMARSH GEORGE F Director | Sale | −12,000 | $0.75 | $9K | 52,848 |
| 2023-04-18 | TIDMARSH GEORGE F Director | Purchase | +25,000 | $1.16 | $29K | 64,848 |
| 2023-04-17 | TIDMARSH GEORGE F Director | Purchase | +26,500 | $1.16 | $31K | 39,848 |
| 2023-04-14 | TIDMARSH GEORGE F Director | Grant or award · Stock Option (Right to Buy) | +6,356 | 6,356 |
Page 2 of 4 · 64 trades